Inner Banner image

Be a part of International Conference on Cancer-Immunotherapy

About Us


May 18-19, 2022 at 11:00 AM GMT 
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar


Amsterdam, Netherlands

Meetings International invites participants from all over the globe to attend the “International Conference on Cancer Immunotherapy” during May 18-19, 2022 at Amsterdam, Netherlands .which gathers all the people to share their knowledge and have a discussion on the current issue on cancer and development of cancer therapies.  The theme “Research Challenges & Advancements in Cancer and Therapeutic Strategies”. The Conference expertise meet in the field of oncology where oncologists, scientists, researchers, medical students, pharmacists, R& D scholars, medical professors, gynecologists, molecular biologists, bioinformatics students and professors, radiologists, cancer research institutes to exchange ideas, communicate & discuss the research work and about new advancements in the cancer therapy and treatment.


Tracks 1: Cancer Therapy

There are more than 300 types of cancer, including Breast cancer, cervical cancer, lung cancer, rectal cancer, Prostate cancer, and lymphoma. "Signs and Identification differs liable on the type of Cancer." Some people with cancer will have particular treatment. But most people have a synthesis of treatments, such as surgery with chemotherapy and/or acupuncture therapy. The Anticancer therapies include Palliative therapy, Immunotherapy, Hormonal therapy, Radiotherapy, Nutritional therapy, Phototherapy, Surgical therapy, Chemotherapy, Adjuvant therapy, Neoadjuvant therapy. Phototherapy is the most progressive among all the therapies. All Anticancer agents act by disturbing cell multiplication or normal functioning, DNA synthesis and by blocking or changing RNA and protein metabolite. Various therapies has been followed by the introduction of the new drug by clinical trials results, or by passing the cell under some radiations or radioactive waves or by taking some sort of medicine or considering with the alteration in the genetic material or by some sort of particular organ transplant.

  •  Surgical Therapy
  • Photodynamic Therapy
  • Hormonal Therapy
  • Palliative Therapy
  • Adjuvant Therapy

Tracks 2: Cancer Prevention & Research

Cancer prevention is well-defined as active methods to reduction the risk of cancer. Most of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. An entity's risk of increasing cancer can be significantly reduced by healthy behaviour. Cancer Prevention Research embraces preclinical, clinical and translational research, with special attention given to molecular detection and an emphasis on building a translational bridge between the basic and clinical sciences.

  • Oncogenesis
  • Avoiding Risk Factors
  • Changing Lifestyle Choices
  • Preclinical & Clinical Research
  • Early Detection Research
  • Immunoprevention
  • Chemo preventive Measures

Track 3: Cancer Cell Biology & Genetics 

Cancer is caused when cells within the body accumulate genetic mutations and start to grow in an uncontrolled manner. Understanding how cancer develops and progresses, including how gene mutations drive the growth and spread of cancer cells, and how tumours interact with their surrounding environment, is vital for the discovery of new targeted cancer treatments.

  • Tumour Biology
  • Cancer Epigenetics
  • Oncogenes & Proto-oncogenes
  • Tumour Suppressor Genes

Track 4: Cancer Chemotherapy

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a healing intent, or it may aim to prolong life or to diminish symptoms.

  • Treatment strategies
  • Adverse effects
  • Limitations
  • Cancer Therapeutics, Novel and experimental approaches

Track 5: Cancer Immunology & Immunotherapy

Cancer immunology is a division of immunology that studies deals between the immune system and cancer cells. It is an arena of exploration that aims to ascertain cancer immunotherapies to treat and delay progression of the infection. Immunotherapies can be characterized as active, passive or hybrid (active and passive). The immune response, comprising the recognition of cancer-specific antigens, methods the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

  • Host-Tumor Relation
  • Cancer Immunosurveillance and Immunoediting
  • Clinical Cancer immunology
  • Cancer Antigens & Vaccines
  • Cellular Immunotherapy
  • Antibody Therapy
  • Cytokine Therapy
  • Combination & Combinatorial Ablation and Immunotherapies

Track 6 : Cancer Pharmacology

Cancer pharmacology plays an important role in medication development. In both the laboratory and the hospital, cancer pharmacology has had to adjust to the changing face of drug expansion by forming experimental representations and target orientated methods. It also emphases on developing new approaches to the clinical dealing of cancer over research that bridges the arenas of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It usually involves the pharmacological and oncological aspects of drugs at both.

  • Clinical Toxicology
  • Pharmacokinetics
  • Pharmacodynamics
  • Drug interactions
  • Cancer Drug Targets
  • Molecular Carcinogenesis
  • Biochemical Pharmacology
  • Clinical Pharmacology

Track 7: Cancer Diagnosis

Diagnostics plays an important role throughout Cancer treatment. Before treatment, to accurately locate Tumors, stage the disease, and determine an appropriate combination of cancer diagnosis. Diagnostics are used to track the size of the tumor, progression of the disease, and patient response to treatment, and modify your treatment accordingly. To confirm the diagnosis of most cancers, a liquid Biopsy needs is to be performed in which a tissue sample is removed from the tumor which occurred initially and studied under a microscope for detecting cancer cells. Endoscopy can be done by implanting a flexible plastic tube with a minute camera into body cavities or organs. Cancer Screening tests are used to detect the possibility of tumor cells which is present before symptoms occur. To identify cancer at its initial stage, different types of diagnostic tests are used to Screen at-risk individuals, Monitor treatment efficacy and disease progression or recurrence, Predict prognosis and direct treatment, Monitor an asymptomatic population for the early discovery of cancer, Earlier detection and treatment consequently drops cancer mortality, Diagnose a primary cancer and recognize the cancer .

Track 8: Clinical Oncology

Clinical Oncology embraces full range of Nonsurgical Cancers including the Chemotherapy, Radiotherapy, Palliative care and Biological targeted therapy. Clinical oncologists give Solid tumours with Chemotherapy, Conventional Radiotherapy, Brachytherapy, Biological therapy, Molecular targeted therapy and sometimes with multimodality trades that include the blend of two or more Anti-cancer therapies. Clinical oncologists regulate treatment by considering a range of aspects including tumour type, the site of the tumour, the stage of the disease and the patient’s general health. They then assess the relative merits of different diagnosis before presenting these to the patient so that an informed decision can be made. The branch also comprises the study of Cancer staging, Cancer epidemiology, Brachytherapy, Cancer biostatistics etc.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 9: Radiology and Imaging in Cancer

Radiology is the science used for the analysis and treatment of diseases inside the body with restaurant imagery. A range of imaging solutions is used to analyze or possibly treat diseases, e.g. x-rays, radiographs, ultrasound, recorded tomographic, nuclear pharmaceuticals, including positron discharge tomography (PET) and MRI. Medical imaging aims at revealing inner skin and bone structures and diagnosing and treating disease. Interventional radiology is the execution, with the aim of imaging innovations, of (normally negligible intricate) therapeutic methodology.

Session 10: Molecular Targeted Therapy

A modernized version of pharmacotherapy that blocks the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis and tumor growth, unlike conventional chemotherapy that interferes with all rapidly dividing cells. Molecular Targeted Therapy is the expected to be a more effective method therapeutically and less harmful to the normal cells in the body. This particular session of the Cancer Treatment Conference shall emphasize on the targeted therapies for various types of cancers and how its effectiveness is greater compared to the rest of the conventional treatments.

Session 11: Regenerative Medicine

Regenerative medicines are a branch of translational research that includes ability of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself to establish normal functioning of the body. The advancements in the field are vast as extracellular matrix materials are now commercially available and are used in re-constructive surgery, treating chronic wounds as well as some orthopedic surgeries; as the reports of January 2017 clinical studies, it was under way to use them in heart surgery to repair damaged heart tissue. This session at the Cancer Therapy 2018 Conference shall be about the future prospects and vital improvisations that can be brought about for this therapeutic process.

Session 12: Hormonal Therapy

This strategy is generally used along with other treatments if the hormones interfere with the cancer. Also known as Endocrine therapy, its administration methods can be oral vaccination or surgical depending on the type of cancer.  This session of the Oncology Conference will be about how organ removal or hormonal blockage affects people, and advancements in the scientific field about reducing its side effects.


Future of Oncology Sector

Over the past decade, there has been a paradigm shift in the management of cancer, driven by developments in personalized medicine and immuno-oncology. In recent years, several new technologies have arisen with the promise of improving the outcomes of cancer treatments by helping the immune system identify and attack tumours, a field known as immuno-oncology. These technologies could make a big difference in the development of effective options that take us closer to being able to cure cancer. Growing research into cancer and its related branches is changing our understanding of diseases and how to tackle this.

Target Audience

  • Cancer research Students, Scientists
  • Cancer Researchers
  • Cancer research Faculty
  • Medical Colleges
  • Cancer Associations and Societies
  • Oncologists
  • Radiologists
  • Chemotherapists
  • Pathologists
  • Physicians
  • Medical Devices Manufacturing Companies
  • Pharmaceutical Companies
  • Diagnostics Companies

Why to attend

  • Stay up to date about the Cancer and its care
  • Gain Practical strategy to fight Cancer
  • Find an innovative solution to root our cancer
  • Be inspired & energized
  • Grow your professional network

Market value in France

As per some research, the worldwide market value of cancer therapies is expected to grow at a compound annual growth rate of 7.4 percent between 2017 and 2022 of the $121 billion in 2016, down to $172.6 billion by 2022. The global cancer therapy market was valued at USD 136,254.35 million in 2018, and is estimated to reach USD 220,701.26 million in 2024.

prominent factors that are driving the oncology related market growth include increasing patient assistance programs(PAPs), increasing, government initiatives for cancer awareness, rising prevalence of cancer worldwide and strong R&D initiatives from key players.

Market value in Europe

In 2017, the worldwide drug market for oncology and cancer was estimated at around 1 lakh million dollars and expected to reach around 1.8 lakh million dollars by 2025. Spending on cancer medicines totalled at $107 billion worldwide in 2015 and is projected to exceed $150 billion by 2020, reflecting adoption of newer, pricier therapies, according to a report from leading healthcare organization.

Global Market Value

As per some leading market research companies, the global market for oncology therapeutic medicines will reach around $200 billion by 2022, averaging 10—13% growth over the next four years from now. Increasing Patient Assistance Programs (PAPs), increasing public initiatives for knowledge of cancer, increasing global incidence of cancer, and powerful R&D initiatives by important actors can contribute to market development. During the prediction period, the target treatment section will demonstrate the largest growth.

Top Medical Colleges in France

  • University of Paris
  • University of Burgundy
  • University of Angers
  • University of Western Brittany
  • Higher Normal School of Lyon
  • University of Caen Normandy
  • University of Strasbourg
  • Sorbonne University
  • University of Nantes
  • University of Limoges

Top Medical Colleges in Europe

  • Oxford University, UK
  • University of Valencia, Spain
  • Cambridge University, UK
  • The Karolinska Institute, Sweden
  • Uppsala University, Sweden
  • Heidelberg University, Germany
  • The University of Copenhagen, Denmark
  • Hamburg University, Germany
  • Erasmus University Rotterdam, Netherlands
  • Pavia University, Italy

Worldwide Top Medical Colleges

  • Johns Hopkins University, USA
  • Stanford University, USA
  • Imperial College of London, UK
  • Cambridge University, UK
  • RWTH Aachen University, Germany
  • Northern Ontario School of Medicine, Canada
  • The University of Melbourne, Australia
  • National University of Singapore, Singapore
  • The University of Tokyo, Japan
  • The University of Hong Kong, Hong Kong

Top Pharma companies in world

  • Lupin Limited
  • Glenmark Pharmaceuticals
  • Cipla
  • Cadila Healthcare
  • Wockhardt
  • Roche Holding AG
  • Bristol-Myers Squibb
  • Amgen
  • Sanofi
  • Pfizer


Globally the costs related with cancer care are higher than the treatment for any other disease, so it leads to the demand for creating a more robust way to find some alternative. Innovative treatments will play a vital role in cancer research and diagnosis sector in the near future. The future paradigm shift requires some fundamental changes and Cancer 2020 will follow that goal to put a small step towards cancer free society.



Meetings International is announcing Young Scientist Awards through Cancer immunotherapy Conference which is scheduled at Amsterdam, Netherlands during May 18-19, 2022. This Cancer immunotherapy conference focuses on Current Emerging Practices in Clinical and Experimental Cancer immunotherapy.

Cancer immunotherapy 2022 and upcoming conferences will recognize participants who have significantly added value to the scientific community of Medical science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.


Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

Acknowledgement as YRF Awardee

Promotion on the conference website, Young Researcher Awards and certificates

Link on the conference website

Recognition on Meetings Int. Award Page

Chances to coordinate with partners around the world

Research work can be published in the relevant journal without any publication fee


All presented abstracts will automatically be considered for the Award.

All the presentation will be evaluated in the conference venue

All the awards will be selected by the judges of the award category

The winners of the Young Scientist Award will receive award certificate.

The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.


All submissions must be in English.

The topic must fit into scientific sessions of the conference

Each individual participant is allowed to submit maximum 2 papers

Abstract must be submitted online as per the given abstract template

Abstracts must be written in Times New Roman and font size will be 12

Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Cancer immunotherapy Science Conference.

Cancer immunotherapy 2022 helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine. We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company. If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains. We maintain high quality and ethical standards of publication industry, which make us unique and better than the rest. Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals or relevant equipment or services, here is the opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide. Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations and high-level individuals, dedicated to host world class conferences and events. Meetings International supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry. Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement. For further queries, connect our conference manager at

you can also connect us via WhatsApp: +65 3158 1626 / + 44 122980269

Google Analytics Metrics of Infectious 2021:

The visitor’s traffic is the benchmark for the success of conference and Infectious Diseases 2021 is constantly attracting viewers across the world.

According to the Google Analytics, more than 100+ monthly audiences are visiting to our conference websites for submitting abstracts; brochure downloads registration, exhibition and sponsorship queries.

Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

437,380 + Users

1,606,987 + Page views

644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers. The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.


Meet Experts

Global Networking

Learning In a New Space

New Tips & Tactics